This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...

Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

For the first time, scientists say new therapies have the power to cure sickle cell disease. The disease is a devastating, ...

Chronic lower back pain can be debilitating, keeping individuals away from work, family, and daily life. For Oklahoma City ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Omidubicel is a nicotinamide modified unrelated allogeneic hematopoietic progenitor cell therapy derived from cord blood.

A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the ...

Saved from precursor B-cell acute lymphoblastic leukemia, the Nobel Prize winning CAR T-cell therapy gave Bryn Ailinger a ...